Ascendis Pharma A/S - Ordinary Share (ASND) is listed on NASDAQ in Pharmaceutical Stocks. It is $248.08, -0.51%. RSI is 44.5, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 44.5 Neutral
Volume 382.6K
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Bienaime Jean Jacques | Insider | Buy | 2,000 | $246.33 | $492,654 | 2026 Aug 14 |
| Smith Scott Thomas | EVP & Chief Financial Officer | Buy | 100 | $219.00 | $21,900 | 2026 Jun 2 |
| Bienaime Jean Jacques | Insider | Buy | 500 | $223.12 | $111,562 | 2026 May 29 |
| Smith Scott Thomas | EVP & Chief Financial Officer | Buy | 250 | $223.32 | $55,830 | 2026 May 29 |
| Bienaime Jean Jacques | Insider | Buy | 400 | $237.80 | $95,121 | 2026 May 26 |
| Jensen Flemming Steen | Insider | Sell | 19,460 | $238.49 | $4.6M | 2026 May 11 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
Take ASND further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put ASND in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Ascendis Pharma A/S - Ordinary Share next reports.
Set alerts on ASND
Get notified when Ascendis Pharma A/S - Ordinary Share hits your price targets or technical conditions are met.
Get Started Free